A mouse model was firstly developed to assess the effect of maternal vaccination with CPS conjugates on GBS vaginal colonization, ascending infection to uterus and neonatal outcome (mouse model of GBS perinatal infection, Supplementary Figure 1A). This evidence concerns the gene CAD and Guillain-Barre syndrome.